Log in to save to my catalogue

Efficacy, safety and recurrence of new progestins and selective progesterone receptor modulator for...

Efficacy, safety and recurrence of new progestins and selective progesterone receptor modulator for...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8373f2569d8944a8b3fa3cb038001553

Efficacy, safety and recurrence of new progestins and selective progesterone receptor modulator for the treatment of endometriosis: a comparison study in mice

About this item

Full title

Efficacy, safety and recurrence of new progestins and selective progesterone receptor modulator for the treatment of endometriosis: a comparison study in mice

Publisher

England: BioMed Central Ltd

Journal title

Reproductive biology and endocrinology, 2018-04, Vol.16 (1), p.32-13, Article 32

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Current medical treatments for endometriosis are very limited. Progestin and selective progesterone receptor modulators (SPRM) are developed but their efficacy, safety, mechanism and recurrence in endometriosis are not fully studied.
In order to compare therapeutic, side effects and therapeutic actions of Esmya, Duphaston and Dienogest in endome...

Alternative Titles

Full title

Efficacy, safety and recurrence of new progestins and selective progesterone receptor modulator for the treatment of endometriosis: a comparison study in mice

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_8373f2569d8944a8b3fa3cb038001553

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8373f2569d8944a8b3fa3cb038001553

Other Identifiers

ISSN

1477-7827

E-ISSN

1477-7827

DOI

10.1186/s12958-018-0347-9

How to access this item